Company Tagline
Tumor Activated Therapy: targeting Tumor Micro-Environment functional proteins to induce tumor self-destruction
Industry Category
Business Keywords
Company Description
Seekyo Therapeutics is a pioneering biotechnology research company focused on developing innovative therapies for solid cancers. By targeting specific functional proteins selectively produced within the Tumor Micro-Environment (TME), Seekyo Therapeutics is developing a novel approach to cancer treatment. Their lead compound, SKY01, induces selective tumor self-destruction, demonstrating promising efficacy and safety profiles in preclinical studies.
Seekyo Therapeutics is dedicated to advancing cancer treatment through groundbreaking research and development. Their innovative approach has shown unprecedented antitumor efficacy compared to standards of care and has proven effective in various tumors, including pancreas, triple-negative breast cancer, lung, and colorectal cancers. With a focus on low cost of goods, Seekyo Therapeutics aims to make its therapies accessible to a wider patient population. The company's primary address is 2 av Galilée, Futuroscope, Chasseneuil-du-Poitou, Nouvelle-Aquitaine 86360, FR.
With its innovative tumor-activated therapy, Seekyo Therapeutics is poised to revolutionize cancer treatment. The company's commitment to research and development, combined with its focus on efficacy and safety, positions it as a leader in the biotechnology industry. We invite the manager of Seekyo Therapeutics to create a customized and exclusive company showcase and product listing on our platform to further amplify their reach and impact.
Key Personnel / Employees
Compare Companies Side by Side
Compare Seekyo Therapeutics with 3 companies in Biotechnology-Research
| Comparison Field |
Se
Seekyo TherapeuticsMain Company |
CDR-Life Inc.View Profile |
Cytecare HospitalsView Profile |
NeoPhore LtdView Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2017 | 2014 | 2017 |
|
Company Size
|
— | 51-200 | 201-500 | 2-10 |
|
City
|
Horgen, Zurich | Bangalore, Karnataka | Cambridge, Cambridgeshire | |
|
Country
|
Switzerland | India | United Kingdom | |
|
Skills & Keywords
Comparing with main company
|
27 Total Skills
Biotechnology
Cancer Treatment
Tumor Microenvironment
Oncology
Therapeutic Vectors
Drug Delivery
Molecular Platform
Therapeutic vector
Life Science
Cancer treatment
Cancer side effects
Molecular platform
Cancer
breaking through technology
in vitro
Drug Delivery System
breaking through
Smart Molecular System
in vivo
Chemotherapy
Chemotherapy adverse effects
Therapeutic vectors
ADC
Microenvironment
Innovation
Treatment side effects
Adverse effects
|
7 Total
7 Unique
Unique Skills:
Antibody fragments
Drug development
Entrepreneurship
Immuno-oncology
Ophthalmology
Targeted immuno-therapies
+1
|
17 Total
1 Common
16 Unique
Match
4%
Common Skills:
Cancer Treatment
Unique Skills:
Bone Marrow/ Stem Cell Transplant
Breast
Comprehensive Oncology
Diagnostics
GI & Hepatobiliary
Gynaecological
+10
|
5 Total
5 Unique
Unique Skills:
Drug Discovery
Genetics
Immuno-oncology
Small Molecule Therapeutics
Translational Medicine
|
4
Total Companies2014
Oldest Founded3
Countries54
Unique SkillsSimilar Companies
Other organizations in the same industry
Sampling Human
Biotechnology-ResearchSingle cell analysis at massive scale.
Period Pill
Biotechnology-ResearchActively Fund Raising for Phase 2 Clinical Trial.A Revolutionary Solution for Women Fixing the Disco...
Canadian Clinical Cannabinoids Inc.
Biotechnology-ResearchHome to The Loud Plug, Benny Blunto, TERP GUSH, and The Republic
Alternative Company Names
This company is also known as